Outsourcing

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Articles

Capacity is a pivotal commodity in the contract manufacturing business. If you have enough of the right kind of capacity, it's like platinum; conversely, too much of the wrong kind of capacity is like tin.

Outsourcing Outlook

The 2001 POMA Sourcing Survey declares 2001 a good year for drug development and manufacturing outsourcing.

Recovery of the contract services industry picked up steam in the quarter ending 30 June 2001.

Evaluating a CRO should involve acquiring feedback from various personnel within the CRO, ranging from executives to line workers.

360&#176 Feedback &#45 Improving the Selection Process All the Way Around

This project­based quality­improvement program uses short­term goals to achieve the long­term objectives of constant, continuous improvement.

Six Sigma Can Give Contractors a Quality Advantage

The author forecasts industry mergers and acquisitions activities.

The consolidation of the contract manufacturing industry has spread to the parenteral fill-finish segment, with two deals announced just before this year's Fourth of July holiday.

The vulnerability of both the sponsors and the contractors has increased tremendously.

Stakes Rise for Blown Batches

The author reviews year-to-date progress and growth in the pharmaceutical outsourcing industry.

Numerous risks are inherent to the process of outsourcing. The first line of defense for all parties is continuous diligence.